| Year |
Citation |
Score |
| 2010 |
Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Molecular Endocrinology (Baltimore, Md.). 24: 359-69. PMID 20032195 DOI: 10.1210/Me.2009-0346 |
0.333 |
|
| 2010 |
Barhoover MA, Hall JM, Greenlee WF, Thomas RS. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Molecular Pharmacology. 77: 195-201. PMID 19917880 DOI: 10.1124/Mol.109.059675 |
0.319 |
|
| 2001 |
Greenlee WF, Hushka LJ, Hushka DR. Molecular Basis of Dioxin Actions: Evidence Supporting Chemoprotection Toxicologic Pathology. 29: 6-7. PMID 11215685 DOI: 10.1080/019262301301418810 |
0.367 |
|
| 1999 |
Starr TB, Greenlee WF, Neal RA, Poland A, Sutter TR. The trouble with TEFs. Environmental Health Perspectives. 107: A492-3. PMID 10504157 DOI: 10.1289/Ehp.107-1566591 |
0.609 |
|
| 1997 |
Kress S, Greenlee WF. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Research. 57: 1264-9. PMID 9102211 |
0.32 |
|
| 1991 |
Rosenbach T, Greenlee WF. Inositol phosphate formation in the human squamous cell carcinoma line SCC-12 F: studies with bradykinin, the calcium ionophore A23187, and sodium fluoride. The Journal of Investigative Dermatology. 96: 116-22. PMID 1987286 DOI: 10.1111/1523-1747.Ep12515929 |
0.419 |
|
| 1991 |
Sutter TR, Guzman K, Dold KM, Greenlee WF. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science (New York, N.Y.). 254: 415-8. PMID 1925598 DOI: 10.1126/Science.1925598 |
0.318 |
|
| 1990 |
Dold KM, Greenlee WF. Filtration assay for quantitation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) specific binding to whole cells in culture. Analytical Biochemistry. 184: 67-73. PMID 2157351 DOI: 10.1016/0003-2697(90)90013-Y |
0.392 |
|
| 1989 |
Cook JC, Greenlee WF. Characterization of a specific binding protein for 2,3,7,8-tetrachlorodibenzo-p-dioxin in human thymic epithelial cells. Molecular Pharmacology. 35: 713-9. PMID 2542760 |
0.326 |
|
| 1987 |
Cook JC, Dold KM, Greenlee WF. An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus. Toxicology and Applied Pharmacology. 89: 256-68. PMID 3037728 DOI: 10.1016/0041-008X(87)90046-9 |
0.447 |
|
| 1987 |
Cook JC, Gaido KW, Greenlee WF. Ah receptor: relevance of mechanistic studies to human risk assessment. Environmental Health Perspectives. 76: 71-7. PMID 2834195 DOI: 10.1289/Ehp.877671 |
0.386 |
|
| 1987 |
Osborne R, Dold KM, Greenlee WF. Evidence that 2,3,7,8-tetrachlorodibenzo-p-dioxin and thyroid hormones act through different mechanisms in human keratinocytes. Toxicology and Applied Pharmacology. 90: 522-31. PMID 2444020 DOI: 10.1016/0041-008X(87)90144-X |
0.351 |
|
| 1986 |
Hudson LG, Toscano WA, Greenlee WF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicology and Applied Pharmacology. 82: 481-92. PMID 3952731 DOI: 10.1016/0041-008X(86)90283-8 |
0.599 |
|
| 1986 |
Luster MI, Hong LH, Osborne R, Blank JA, Clark G, Silver MT, Boorman GA, Greenlee WF. 1-amino-3,7,8-trichlorodibenzo-P-dioxin: A specific antagonist for TCDD-induced myelotoxicity Biochemical and Biophysical Research Communications. 139: 747-756. PMID 3021141 DOI: 10.1016/S0006-291X(86)80054-7 |
0.425 |
|
| 1985 |
Luster MI, Hong LH, Boorman GA, Clark G, Hayes HT, Greenlee WF, Dold K, Tucker AN. Acute myelotoxic responses in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology and Applied Pharmacology. 81: 156-65. PMID 2996177 DOI: 10.1016/0041-008X(85)90130-9 |
0.427 |
|
| 1985 |
Greenlee WF, Dold KM, Irons RD, Osborne R. Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicology and Applied Pharmacology. 79: 112-20. PMID 2996175 DOI: 10.1016/0041-008X(85)90373-4 |
0.4 |
|
| 1985 |
Greenlee WF, Osborne R, Dold KM, Hudson LG, Toscano WA. Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment. Environmental Health Perspectives. 60: 69-76. PMID 2992929 DOI: 10.1289/Ehp.856069 |
0.606 |
|
| 1985 |
Osborne R, Greenlee WF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. Toxicology and Applied Pharmacology. 77: 434-43. PMID 2579475 DOI: 10.1016/0041-008X(85)90183-8 |
0.412 |
|
| 1985 |
Hudson LG, Toscano WA, Greenlee WF. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 77: 251-9. PMID 2579474 DOI: 10.1016/0041-008X(85)90324-2 |
0.59 |
|
| 1985 |
Greenlee WF, Dold KM, Osborne R. Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture. In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association. 21: 509-12. PMID 2413004 DOI: 10.1007/Bf02620843 |
0.414 |
|
| 1983 |
Hudson LG, Shaikh R, Toscano WA, Greenlee WF. Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochemical and Biophysical Research Communications. 115: 611-7. PMID 6312985 DOI: 10.1016/S0006-291X(83)80188-0 |
0.609 |
|
| 1983 |
Greenlee W, Young M, Atkins W, Hudson L, Dorflinger L, Toscano W. Regulation of adenylate cyclase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-P-Dioxin (TCDD) Toxicology Letters. 18: 5. DOI: 10.1016/0378-4274(83)90294-1 |
0.387 |
|
| 1981 |
Wierda D, Irons RD, Greenlee WF. Immunotoxicity in C57BL/6 mice exposed to benzene and Aroclor 1254. Toxicology and Applied Pharmacology. 60: 410-7. PMID 6794184 DOI: 10.1016/0041-008X(81)90325-2 |
0.351 |
|
| 1981 |
Greenlee WF, Irons RD. Modulation of benzene-induced lymphocytopenia in the rat by 2,4,5,2',4',5'-hexachlorobiphenyl and 3,4,3',4'-tetrachlorobiphenyl. Chemico-Biological Interactions. 33: 345-60. PMID 6780202 DOI: 10.1016/0009-2797(81)90052-1 |
0.305 |
|
| 1979 |
Greenlee WF, Poland A. Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice; Role of the hepatic cytosol receptor protein Journal of Biological Chemistry. 254: 9814-9821. PMID 489572 |
0.636 |
|
| 1979 |
Poland A, Greenlee WF, Kende AS. Studies on the mechanism of action of the chlorinated dibenzo-p-dioxins and related compounds. Annals of the New York Academy of Sciences. 320: 214-30. PMID 110192 DOI: 10.1111/J.1749-6632.1979.Tb56603.X |
0.618 |
|
| 1978 |
Greenlee WF, Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin Journal of Pharmacology and Experimental Therapeutics. 205: 596-605. PMID 660532 |
0.636 |
|
| Show low-probability matches. |